• 1. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

Introduction to 4-(2-Ethoxyethoxy)-3-iodobenzoic Acid (CAS No. 1131614-52-2)

4-(2-Ethoxyethoxy)-3-iodobenzoic acid, identified by its Chemical Abstracts Service (CAS) number 1131614-52-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound belongs to the class of benzoic acid derivatives, characterized by its unique structural features that include an iodine substituent at the 3-position and an ethoxyethoxy group at the 4-position. The presence of these functional groups imparts distinct chemical properties, making it a valuable intermediate in the synthesis of various biologically active molecules.

The structure of 4-(2-Ethoxyethoxy)-3-iodobenzoic acid contributes to its reactivity and utility in synthetic chemistry. The iodine atom at the 3-position serves as a versatile handle for further functionalization, enabling the construction of more complex molecular architectures through cross-coupling reactions such as Suzuki-Miyaura or Stille couplings. Additionally, the ethoxyethoxy side chain introduces a hydrophilic character, which can be beneficial in designing molecules with improved solubility and bioavailability.

In recent years, there has been growing interest in benzoic acid derivatives as pharmacophores due to their demonstrated efficacy in modulating various biological pathways. Among these derivatives, compounds containing iodine substituents have been particularly studied for their potential applications in drug development. The iodinated benzoic acids, including 4-(2-Ethoxyethoxy)-3-iodobenzoic acid, have shown promise as intermediates in the synthesis of kinase inhibitors, anticancer agents, and antimicrobial compounds.

One of the most compelling aspects of 4-(2-Ethoxyethoxy)-3-iodobenzoic acid is its role in the development of targeted therapeutics. The ability to modify its structure allows researchers to fine-tune its interactions with biological targets, enhancing potency and selectivity. For instance, recent studies have highlighted its utility in the synthesis of small-molecule inhibitors targeting protein-protein interactions (PPIs) involved in cancer progression. These inhibitors leverage the iodine atom for covalent binding to cysteine residues in target proteins, leading to potent and irreversible inhibition.

The synthetic pathways for preparing 4-(2-Ethoxyethoxy)-3-iodobenzoic acid typically involve multi-step organic transformations starting from commercially available benzoic acid precursors. Key steps often include halogenation at the desired position, followed by etherification to introduce the ethoxyethoxy group. Advances in catalytic methods have enabled more efficient and sustainable synthetic routes, reducing waste and improving yields. These developments align with broader trends in green chemistry aimed at minimizing environmental impact while maintaining high chemical purity.

From a biochemical perspective, 4-(2-Ethoxyethoxy)-3-iodobenzoic acid has been explored for its potential role as a tool compound in mechanistic studies. Its structural features allow researchers to probe enzyme activity and substrate specificity through derivatization and labeling strategies. For example, it has been used as a probe to study the catalytic mechanisms of cytochrome P450 enzymes, which are crucial for drug metabolism. Understanding these mechanisms is essential for optimizing drug design and predicting metabolic stability.

The pharmaceutical industry has also shown interest in iodinated benzoic acids due to their potential as imaging agents. Iodine-125 or Iodine-131 labeled derivatives of this compound have been investigated for use in positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. These imaging techniques provide non-invasive ways to visualize biological processes and monitor disease progression or treatment response. The versatility of 4-(2-Ethoxyethoxy)-3-iodobenzoic acid makes it a promising candidate for developing novel diagnostic tools.

In conclusion, 4-(2-Ethoxyethoxy)-3-iodobenzoic acid (CAS No. 1131614-52-2) represents a significant advancement in medicinal chemistry due to its unique structural properties and broad applicability. Its role as an intermediate in drug synthesis, coupled with its utility as a tool compound for biochemical research and imaging applications, underscores its importance in modern pharmaceutical development. As research continues to uncover new therapeutic targets and synthetic methodologies, compounds like this will remain indispensable in advancing both academic science and industrial applications.

• 282087-44-9(4-Iodo-3-methoxybenzenecarboxylic acid)
• 1131614-40-8(Ethyl 4-acetoxy-3-iodobenzoate)
• 1131588-12-9(3-Iodo-4-propoxybenzoic acid)
• 842-35-3( )
• 68507-19-7(3-Iodo-4-methoxybenzoic acid)
• 856167-47-0(3-Iodo-4-isopropoxybenzoicacid)
• 207115-38-6(Ethyl 3-iodo-4-methoxybenzoate)
• 741699-04-7(Ethyl 3-ethoxy-4-iodobenzoate)
• 82998-76-3(4-Ethoxy-3-iodobenzoic acid)
• 1131614-46-4(Ethyl 3-iodo-4-propoxybenzoate)